Healthcare & Life Sciences
CrossBridge Bio
United Stateswww.crossbridgebio.com/
CrossBridge Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About CrossBridge Bio
CrossBridge Bio is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
CrossBridge Bio, launched in 2023, develops next-generation antibody-drug conjugates (ADCs) to address a range of cancer indications using technology developed at the University of Texas Health Science Center at Houston.
Explore CrossBridge Bio's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.